1. Home
  2. Live Updates
  3. நிர்வாகி துணை ப்ரெஸிடெஂட் தாமஸ் ட்ரியொஂஃப்

நிர்வாகி துணை ப்ரெஸிடெஂட் தாமஸ் ட்ரியொஂஃப் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நிர்வாகி துணை ப்ரெஸிடெஂட் தாமஸ் ட்ரியொஂஃப். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நிர்வாகி துணை ப்ரெஸிடெஂட் தாமஸ் ட்ரியொஂஃப் Today - Breaking & Trending Today

GSK, Sanofi restart testing for COVID-19 vaccine after delay


GSK, Sanofi restart testing for COVID-19 vaccine after delay
By
(0)
We are confident our vaccine candidate has strong potential and we are very encouraged by the latest preclinical data, a pharma executive said of the vaccine Monday. File Photo by EPA-EFE
Feb. 22 (UPI) Pharma companies GlaxoSmithKline and Sanofi announced Monday that they have begun a second-stage clinical trial for their protein-based COVID-19 vaccine, after testing was delayed in December.
The drugmakers said more than 700 volunteers are involved in the Stage 2 testing for its protein-based adjuvanted coronavirus vaccine.
Advertisement
GSK and Sanofi delayed trials in December after finding that the vaccine wasn t promoting enough of an immune response in older people. Monday s announcement said developers improved the vaccine formulation and the new testing phase includes older adults. ....

United States , Thomas Triomphe , Roger Connor , Executive Vice President Thomas Triomphe , President Roger Connor , Translate Bio , Top News , Covid 19 , ஒன்றுபட்டது மாநிலங்களில் , தாமஸ் ட்ரியொஂஃப் , ரோஜர் இணைப்பான் , நிர்வாகி துணை ப்ரெஸிடெஂட் தாமஸ் ட்ரியொஂஃப் , ப்ரெஸிடெஂட் ரோஜர் இணைப்பான் , மொழிபெயர் உயிர் , மேல் செய்தி ,

Meriden-based Protein Sciences' parent company to make Pfizer vaccine


Meriden-based Protein Sciences’ parent company to make Pfizer vaccine
Meriden-based Protein Sciences’ parent company to make Pfizer vaccine
Clem Lewin, associate vice president of research and development strategy at Sanofi, speaks to the media as Lt. Gov. Susan Bysiewicz, left, Connecticut Gov. Ned Lamont, second from right, and Mireli Fino, site head at Protein Sciences, listen during visit by the governor to Protein Sciences, Thursday, March 12, 2020, in Meriden. (AP Photo/Jessica Hill)
January 27, 2021 06:14PM
By Mary Ellen Godin, Record-Journal staff
Sanofi Pasteur, parent company of Meriden-based Protein Sciences, has agreed to manufacture the Pfizer BioNTech vaccine after clinical trials of its own vaccine were delayed in December, the company announced this week. ....

United States , France General , Sanofi Pasteur , Thomas Triomphe , Paul Hudson , Protein Sciences , Biomedical Advanced Research , Development Authority , Protein Sciences On Research Parkway In Meriden , Meriden Based Protein Sciences , North American , Research Parkway , Executive Vice President Thomas Triomphe , Translate Bio , Record Journal , North Haven , Town Times , Local News , State News , Regional News , Central Connecticut , Front Porch , ஒன்றுபட்டது மாநிலங்களில் , பிரான்ஸ் ஜநரல் , சனோஃபி பாஸ்டர் , தாமஸ் ட்ரியொஂஃப் ,